| Recruitment status | Enrolling by invitation |
| Unique ID issued by UMIN | UMIN000041245 |
| Receipt No. | R000047100 |
| Scientific Title | Examination of the influence on the circulatory system by the airway management method using Nasal High Flow load device AIRVO during sedation |
| Date of disclosure of the study information | 2020/07/29 |
| Last modified on | 2021/01/28 (Ver. 2) |
| Basic information | ||
| Public title | Examination of the influence on the circulatory system by the airway management method using Nasal High Flow load device AIRVO during sedation | |
| Acronym | Examination of the influence on the circulatory system by the airway management method using Nasal High Flow load device AIRVO during sedation | |
| Scientific Title | Examination of the influence on the circulatory system by the airway management method using Nasal High Flow load device AIRVO during sedation | |
| Scientific Title:Acronym | Examination of the influence on the circulatory system by the airway management method using Nasal High Flow load device AIRVO during sedation | |
| Region |
|
|
| Condition | |||
| Condition | DENTISTRY | ||
| Classification by specialty |
|
||
| Classification by malignancy | Others | ||
| Genomic information | NO | ||
| Objectives | |
| Narrative objectives1 | The purpose of this study is to investigate whether the application of NHF increases the intrathoracic pressure and decreases the afterload, and secondarily increases the cardiac output. |
| Basic objectives2 | Others |
| Basic objectives -Others | The purpose of this study is to investigate whether the application of NHF increases the intrathoracic pressure and decreases the afterload, and secondarily increases the cardiac output. |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Estimated afterload and cardiac output during waking and sedation |
| Key secondary outcomes | Tidal volume and respiratory rate during waking and sedation |
| Base | |
| Study type | Observational |
| Study design | |
| Basic design | |
| Randomization | |
| Randomization unit | |
| Blinding | |
| Control | |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |
| No. of arms | |
| Purpose of intervention | |
| Type of intervention | |
| Interventions/Control_1 | |
| Interventions/Control_2 | |
| Interventions/Control_3 | |
| Interventions/Control_4 | |
| Interventions/Control_5 | |
| Interventions/Control_6 | |
| Interventions/Control_7 | |
| Interventions/Control_8 | |
| Interventions/Control_9 | |
| Interventions/Control_10 | |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | Twenty adult healthy volunteers (volunteers) who agreed with the explanation of the content of the research plan are targeted. | |||
| Key exclusion criteria | 1) Patients with serious respiratory illness (asthma)
2) Patients with serious cardiovascular disease (congenital heart disease) 3) Uncontrolled diabetic patients 4) Patients with severe renal impairment 5) Patients with severe liver damage 6) Patients with hypersensitivity (allergy) to the drug to be used 7) Patients judged to be unsuitable by the research supervisor or the research co-workers |
|||
| Target sample size | 20 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | Nagasaki University | ||||||
| Division name | Dental Anesthesiology | ||||||
| Zip code | 8528588 | ||||||
| Address | Sakamoto Nagasaki Japan | ||||||
| TEL | 81958197713 | ||||||
| ayuse@nagasaki-u.ac.jp | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | Nagasaki University | ||||||
| Division name | Dental Anesthesiology | ||||||
| Zip code | 8528588 | ||||||
| Address | Sakamoto Nagasaki Japan | ||||||
| TEL | 81958197713 | ||||||
| Homepage URL | |||||||
| ayuse@nagasaki-u.ac.jp | |||||||
| Sponsor | |
| Institute | Nagasaki University |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Nagasaki University |
| Organization | |
| Division | |
| Category of Funding Organization | Other |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | Nagasaki University |
| Address | Sakamoto Nagasaki Japan |
| Tel | 81958197713 |
| ayuse@nagasaki-u.ac.jp | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| Result | |
| URL related to results and publications | |
| Number of participants that the trial has enrolled | |
| Results | |
| Results date posted | |
| Results Delayed | |
| Results Delay Reason | |
| Date of the first journal publication of results | |
| Baseline Characteristics | |
| Participant flow | |
| Adverse events | |
| Outcome measures | |
| Plan to share IPD | |
| IPD sharing Plan description | |
| Progress | |||||||
| Recruitment status | Enrolling by invitation | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Other | |
| Other related information | NONE |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000047100 |